Memory Disorders News Today

Chris Hemsworth series exploring how to discover the full potential of the human body, to screen on Nine.

Alzheimer's Disease and related dementias take a heavy toll on individuals and their caregivers. New medications offer hope, but raise accessibility concerns.

Experts say misplacing keys or other everyday items isn't necessarily a sign of dementia or other serious memory loss issues. They note there are ways you can keep your memory sharp.

Significantly higher rate of improvement in ADAS-Cog 11 scores in each treatment dose relative to placebo for patients with mild ADImprovement in cognition measured by ADAS-Cog 11 at three months is...

Food and Drug Administration approved Leqembi last year

(Repeats to additional subscribers with no changes to text ) By Julie Steenhuysen CHICAGO (Reuters) -Nine months into the U.S. launch of the first drug proven to slow the advance of Alzheimer's, Eisai and Biogen's Leqembi is facing an unexpected hurdle...

Nine months into the U.S. launch of the first drug proven to slow the advance of Alzheimers, Eisai and Biogens Leqembi is facing an unexpected hurdle to widespread use: an entrenched belief among some doctors that treating the memory-robbing disease is futile.

CHICAGO (Reuters) -Nine months into the U.S. launch of the first drug proven to slow the advance of Alzheimer's, Eisai and Biogen's Leqembi is facing an unexpected hurdle to widespread use: an entrenched belief among some doctors that treating the memory-robbing disease is futile. Alzheimer's experts had anticipated bottlenecks due to Leqembi's requirements, which include additional diagnostic tests, twice-monthly infusions and regular brain scans to guard against potentiall...

The adoption of the FDA-approved Alzheimer's drug, Leqimbi, has slowed down in the U.S. as more experts grow hesitant about the drugs cost, risks and efficacy.

A collaboration involving Florida researchers is expanding efforts to develop a blood test for Alzheimer’s disease.